Beximco Pharma receives US FDA approval for Flecainide Acetate Tabs

September 21st, 2020- Bayshore Pharmaceuticals’ manufacturing partner, Beximco Pharmaceuticals, received US FDA approval for Flecainide Acetate (50, 100 and 150 mg tablets), an antiarrythmic drug used for treating irregular heartbeats. Product launch timing will be disclosed shortly.

https://thefinancialexpress.com.bd/home/beximco-pharma-receives-us-fda-approval-for-flecainide-1600689153?amp=true